Author: Tomasz Mroczkowski
Publisher: Pearson Education
ISBN: 0132172968
Category : Business & Economics
Languages : en
Pages : 354
Book Description
The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.
The New Players in Life Science Innovation
Author: Tomasz Mroczkowski
Publisher: Pearson Education
ISBN: 0132172968
Category : Business & Economics
Languages : en
Pages : 354
Book Description
The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.
Publisher: Pearson Education
ISBN: 0132172968
Category : Business & Economics
Languages : en
Pages : 354
Book Description
The global center of gravity in life sciences innovation is rapidly shifting to emerging economies. In The New Players in Life Science Innovation, Tomasz Mroczkowski explains how China and other new economic powers are rapidly gaining leadership positions, and thoroughly assesses the implications. Mroczkowski discusses the sophisticated innovation strategies and reforms these nations have implemented: approaches that don't rely on market forces alone, and are achieving remarkable success. Next, he previews the emerging global "bio-economy," in which life science discoveries will be applied pervasively in markets ranging from health to fuels. As R&D in the West becomes increasingly costly, Mroczkowski introduces new options for partnering with new players in the field. He thoroughly covers the globalization of clinical trials, showing how it offers opportunities that go far beyond cost reduction, and assessing the unique challenges it presents. Offering examples from China to Dubai to India, he carefully assesses the business models driving today's newest centers of innovation. Readers will find up-to-date coverage of bioparks, technology zones, and emerging clusters, and realistic assessments of global R&D collaboration strategies such as those of Eli Lilly, Merck, Novartis, and IBM. With innovation-driven industries increasingly dominating the global economy, this book's insights are indispensable for every R&D decision-maker and investor.
Innovations in Life Science Research
Author: Rajeshwar P. Sinha
Publisher:
ISBN: 9781536158687
Category :
Languages : en
Pages :
Book Description
Publisher:
ISBN: 9781536158687
Category :
Languages : en
Pages :
Book Description
Financing Life Science Innovation
Author: A. Styhre
Publisher: Springer
ISBN: 1137392487
Category : Business & Economics
Languages : en
Pages : 413
Book Description
Financing Life Science Innovation reviews the literature on venture capital, corporate governance, and life science venturing and presents a study of the Swedish life science industry and the venture capital investors being active in financially and managerially supporting life science start-up firms.
Publisher: Springer
ISBN: 1137392487
Category : Business & Economics
Languages : en
Pages : 413
Book Description
Financing Life Science Innovation reviews the literature on venture capital, corporate governance, and life science venturing and presents a study of the Swedish life science industry and the venture capital investors being active in financially and managerially supporting life science start-up firms.
Leading Pharmaceutical Innovation
Author: Oliver Gassmann
Publisher: Springer
ISBN: 9783319668321
Category : Business & Economics
Languages : en
Pages : 179
Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Publisher: Springer
ISBN: 9783319668321
Category : Business & Economics
Languages : en
Pages : 179
Book Description
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
Science and Innovation
Author: Alfonso Gambardella
Publisher: Cambridge University Press
ISBN: 0521451183
Category : Business & Economics
Languages : en
Pages : 236
Book Description
This book examines an increasingly important phenomenon for competitiveness and innovation in industry: namely, the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are now being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies, and competition. Science and innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences in the 1980s have brought to the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labor between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery, and the productivity of R&D.
Publisher: Cambridge University Press
ISBN: 0521451183
Category : Business & Economics
Languages : en
Pages : 236
Book Description
This book examines an increasingly important phenomenon for competitiveness and innovation in industry: namely, the growing use of scientific principles in industrial research. Industrial innovation still arises from systematic trial-and-error experiments with many designs and objects, but these experiments are now being guided by a more rational understanding of phenomena. This has important implications for market structure, firm strategies, and competition. Science and innovation focuses on the pharmaceutical industry. It discusses the changes that the notable advances in the life sciences in the 1980s have brought to the strategies of drug companies, the organization of their internal research, their relationships with scientific institutions, the division of labor between large pharmaceutical firms and small research-intensive suppliers, the productivity of drug discovery, and the productivity of R&D.
Managing Discovery in the Life Sciences
Author: Philip A. Rea
Publisher: Cambridge University Press
ISBN: 1107130905
Category : Business & Economics
Languages : en
Pages : 557
Book Description
Addresses in roughly equal measure the science and management behind several recent marketable biomedical innovations.
Publisher: Cambridge University Press
ISBN: 1107130905
Category : Business & Economics
Languages : en
Pages : 557
Book Description
Addresses in roughly equal measure the science and management behind several recent marketable biomedical innovations.
The Business of Healthcare Innovation
Author: Lawton R. Burns
Publisher: Cambridge University Press
ISBN: 9780521838986
Category : Business & Economics
Languages : en
Pages : 400
Book Description
The first wide-ranging analysis of business trends in the manufacturing segment of the health care industry.
Publisher: Cambridge University Press
ISBN: 9780521838986
Category : Business & Economics
Languages : en
Pages : 400
Book Description
The first wide-ranging analysis of business trends in the manufacturing segment of the health care industry.
Outsider Scientists
Author: Oren Harman
Publisher: University of Chicago Press
ISBN: 022607854X
Category : Science
Languages : en
Pages : 387
Book Description
Outsider Scientists describes the transformative role played by “outsiders” in the growth of the modern life sciences. Biology, which occupies a special place between the exact and human sciences, has historically attracted many thinkers whose primary training was in other fields: mathematics, physics, chemistry, linguistics, philosophy, history, anthropology, engineering, and even literature. These outsiders brought with them ideas and tools that were foreign to biology, but which, when applied to biological problems, helped to bring about dramatic, and often surprising, breakthroughs. This volume brings together eighteen thought-provoking biographical essays of some of the most remarkable outsiders of the modern era, each written by an authority in the respective field. From Noam Chomsky using linguistics to answer questions about brain architecture, to Erwin Schrödinger contemplating DNA as a physicist would, to Drew Endy tinkering with Biobricks to create new forms of synthetic life, the outsiders featured here make clear just how much there is to gain from disrespecting conventional boundaries. Innovation, it turns out, often relies on importing new ideas from other fields. Without its outsiders, modern biology would hardly be recognizable.
Publisher: University of Chicago Press
ISBN: 022607854X
Category : Science
Languages : en
Pages : 387
Book Description
Outsider Scientists describes the transformative role played by “outsiders” in the growth of the modern life sciences. Biology, which occupies a special place between the exact and human sciences, has historically attracted many thinkers whose primary training was in other fields: mathematics, physics, chemistry, linguistics, philosophy, history, anthropology, engineering, and even literature. These outsiders brought with them ideas and tools that were foreign to biology, but which, when applied to biological problems, helped to bring about dramatic, and often surprising, breakthroughs. This volume brings together eighteen thought-provoking biographical essays of some of the most remarkable outsiders of the modern era, each written by an authority in the respective field. From Noam Chomsky using linguistics to answer questions about brain architecture, to Erwin Schrödinger contemplating DNA as a physicist would, to Drew Endy tinkering with Biobricks to create new forms of synthetic life, the outsiders featured here make clear just how much there is to gain from disrespecting conventional boundaries. Innovation, it turns out, often relies on importing new ideas from other fields. Without its outsiders, modern biology would hardly be recognizable.
Life as We Made It
Author: Beth Shapiro
Publisher: Basic Books
ISBN: 1541644158
Category : Science
Languages : en
Pages : 318
Book Description
From the first dog to the first beefalo, from farming to CRISPR, the human history of remaking nature When the 2020 Nobel Prize was awarded to the inventors of CRISPR, the revolutionary gene-editing tool, it underlined our amazing and apparently novel powers to alter nature. But as biologist Beth Shapiro argues in Life as We Made It, this phenomenon isn’t new. Humans have been reshaping the world around us for ages, from early dogs to modern bacteria modified to pump out insulin. Indeed, she claims, reshaping nature—resetting the course of evolution, ours and others’—is the essence of what our species does. In exploring our evolutionary and cultural history, Shapiro finds a course for the future. If we have always been changing nature to help us survive and thrive, then we need to avoid naive arguments about how we might destroy it with our meddling, and instead ask how we can meddle better. Brilliant and insightful, Life as We Made It is an essential book for the decades to come.
Publisher: Basic Books
ISBN: 1541644158
Category : Science
Languages : en
Pages : 318
Book Description
From the first dog to the first beefalo, from farming to CRISPR, the human history of remaking nature When the 2020 Nobel Prize was awarded to the inventors of CRISPR, the revolutionary gene-editing tool, it underlined our amazing and apparently novel powers to alter nature. But as biologist Beth Shapiro argues in Life as We Made It, this phenomenon isn’t new. Humans have been reshaping the world around us for ages, from early dogs to modern bacteria modified to pump out insulin. Indeed, she claims, reshaping nature—resetting the course of evolution, ours and others’—is the essence of what our species does. In exploring our evolutionary and cultural history, Shapiro finds a course for the future. If we have always been changing nature to help us survive and thrive, then we need to avoid naive arguments about how we might destroy it with our meddling, and instead ask how we can meddle better. Brilliant and insightful, Life as We Made It is an essential book for the decades to come.
The New Health Bioeconomy
Author: James Mittra
Publisher: Palgrave Macmillan
ISBN: 9781349576678
Category : Social Science
Languages : en
Pages : 240
Book Description
This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.
Publisher: Palgrave Macmillan
ISBN: 9781349576678
Category : Social Science
Languages : en
Pages : 240
Book Description
This book provides new insights into how new biology, and the emergence of "translational" policies to drive the health bioeconomy, is reshaping the innovation ecosystem for new therapies. A key argument is that a broader definition of value (beyond the economic aspects) is needed to understand health innovation in the twenty-first century.